[go: up one dir, main page]

ES544162A0 - Procedimiento para preparar derivados de heparina - Google Patents

Procedimiento para preparar derivados de heparina

Info

Publication number
ES544162A0
ES544162A0 ES544162A ES544162A ES544162A0 ES 544162 A0 ES544162 A0 ES 544162A0 ES 544162 A ES544162 A ES 544162A ES 544162 A ES544162 A ES 544162A ES 544162 A0 ES544162 A0 ES 544162A0
Authority
ES
Spain
Prior art keywords
procedure
heparin derivatives
preparing heparin
preparing
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES544162A
Other languages
English (en)
Other versions
ES8608543A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intermedicat GmbH
Original Assignee
Intermedicat GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intermedicat GmbH filed Critical Intermedicat GmbH
Publication of ES8608543A1 publication Critical patent/ES8608543A1/es
Publication of ES544162A0 publication Critical patent/ES544162A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ES544162A 1984-06-16 1985-06-14 Procedimiento para preparar derivados de heparina Expired ES8608543A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843422518 DE3422518A1 (de) 1984-06-16 1984-06-16 Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen

Publications (2)

Publication Number Publication Date
ES8608543A1 ES8608543A1 (es) 1986-06-16
ES544162A0 true ES544162A0 (es) 1986-06-16

Family

ID=6238594

Family Applications (1)

Application Number Title Priority Date Filing Date
ES544162A Expired ES8608543A1 (es) 1984-06-16 1985-06-14 Procedimiento para preparar derivados de heparina

Country Status (6)

Country Link
US (1) US4816446A (es)
EP (1) EP0165569A3 (es)
JP (1) JPS6169802A (es)
DE (1) DE3422518A1 (es)
ES (1) ES8608543A1 (es)
ZA (1) ZA854506B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR243204A1 (es) * 1986-11-21 1993-07-30 Ajorca Sa Un metodo para la depolimerizacion quimica de polisacaridos.
IL85145A (en) * 1987-01-23 1994-08-26 Univ Australian Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity
US5541166A (en) * 1987-01-23 1996-07-30 The Australian National University Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
AU3434889A (en) * 1988-03-15 1989-10-05 Jewish Hospital Of St. Louis, The Inhibition of intestinal cholesterol and fatty acid absorption
IT1234508B (it) * 1988-06-10 1992-05-19 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
EP0355905B1 (en) * 1988-08-24 1993-01-07 Akzo N.V. Heparin fragments and fractions with anti-hiv action
FR2637804B1 (fr) * 1988-10-17 1993-04-09 Sanofi Sa Compositions pharmaceutiques contenant un derive d'heparine partiellement n-desulfate a activite antithrombotique
IT1234826B (it) * 1989-01-30 1992-05-29 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
AR245455A1 (es) * 1989-08-18 1994-01-31 Ajorca Sa Procedimiento para la obtencion de derivados de heparina,parcial o totalmente n-acetilados en el resto glucosaminico y productos asi obtenidos excluidos sus usos farmaceuticos.
US5340932A (en) * 1989-08-18 1994-08-23 Ajorca S.A. Substances with heparin-like structure and their method of production
IT1243987B (it) * 1990-10-29 1994-06-28 Derivati Organici Lab Procedimento per la preparazione di epossi-eparidi prodotti ottenuti ecomposizioni farmaceutiche che li contengono
FR2669932B1 (fr) * 1990-12-03 1994-07-01 Sanofi Sa Nouvel heparosane-n,o-sulfate, son procede de preparation et les compositions pharmaceutiques qui le contiennent.
US5250519A (en) * 1991-03-29 1993-10-05 Glycomed Incorporated Non-anticoagulant heparin derivatives
US5668118A (en) * 1992-07-24 1997-09-16 Cavalier Pharmaceuticals Method of synthesis of 2-O-desulfated Heparin and use thereof for inhibition of elastase and Cathepspin G
IT1264709B1 (it) * 1993-07-12 1996-10-04 Italfarmaco Spa Derivati eparinici ad attivita' antimetastatica
WO1995033468A1 (en) * 1994-06-06 1995-12-14 Oestergaard Per Bjoern A pharmaceutical composition comprising oligosaccharides binding to lipoprotein lipase
CA2341412A1 (en) * 1998-08-27 2000-03-09 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase i and ii
US6933372B2 (en) * 2003-03-07 2005-08-23 Warner-Lambert Company Method to produce a solid form of heparin
US7608246B2 (en) * 2005-09-02 2009-10-27 The Brigham And Women's Hospital, Inc. Apolipoprotein E as an adjuvant for lipid antigens
SG10201914117QA (en) 2012-05-09 2020-02-27 Cantex Pharmaceuticals Inc Treatment Of Myelosuppression
US11116819B2 (en) 2013-02-28 2021-09-14 President And Fellows Of Harvard College Methods and compositions for mobilizing stem cells
EP3258941A4 (en) 2015-02-17 2018-09-26 Cantex Pharmaceuticals, Inc. Treatment of cancers and hematopoietic stem cell disorders privileged by cxcl12-cxcr4 interaction

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3151025A (en) * 1953-10-01 1964-09-29 Philips Roxane Blood lipid clearing composition
GB863235A (en) * 1958-07-05 1961-03-22 Roussel Uclaf Improvements in or relating to organic compounds related to heparin
US3118816A (en) * 1962-04-03 1964-01-21 Abbott Lab N-succinyl heparin and process
CH642669A5 (de) * 1979-12-03 1984-04-30 Meyhall Chemical Ag Wasserloesliches guarprodukt und verfahren zu dessen herstellung.
ATE22899T1 (de) * 1982-06-10 1986-11-15 Kabivitrum Ab Antithrombin-heparin komplex.
IT1169888B (it) * 1983-10-25 1987-06-03 Italfarmaco Spa Glicosaminoglicani modificati dotati di attivita' antitrombotica

Also Published As

Publication number Publication date
ZA854506B (en) 1986-07-30
EP0165569A3 (en) 1987-05-13
ES8608543A1 (es) 1986-06-16
EP0165569A2 (en) 1985-12-27
US4816446A (en) 1989-03-28
DE3422518A1 (de) 1985-12-19
JPS6169802A (ja) 1986-04-10

Similar Documents

Publication Publication Date Title
MX159807A (es) Procedimiento para preparar derivados de bencimidazol
ES546195A0 (es) Procedimiento para preparar derivados de polisacaridos
ES548922A0 (es) Procedimiento para preparar nuevos derivados de aminotetra- lina
ES548445A0 (es) Procedimiento para la obtencion de derivados de azolilmetil-ciclopropil-carbinol sustituido
ES529282A0 (es) Procedimiento para preparar derivados de tiazol
ES540464A0 (es) Procedimiento para preparar derivados de pleuromutilina
ES544162A0 (es) Procedimiento para preparar derivados de heparina
ES539255A0 (es) Procedimiento para preparar derivados de isoquinoleina
ES556156A0 (es) Procedimiento para la obtencion de derivados de la 13-beta-milbemicina
ES550875A0 (es) Procedimiento para preparar derivados de imidazolilalquil- quilguanidina
ES546847A0 (es) Procedimiento para preparar derivados de carbamoilimidazol fungicidas
MX159654A (es) Procedimiento para preparar derivados de hidroxi-4-2h-1-benzotiopiran-2-onas
MX157033A (es) Procedimiento para preparar derivados de pirrolo quinoleina
ES550961A0 (es) Procedimiento para preparar derivados azolilalquilicos
ES552955A0 (es) Procedimiento para preparar derivados de bencimidazol substituidos
MX7403E (es) Procedimiento para preparar derivados de benzoil-ureas
ES534377A0 (es) Procedimiento para preparar derivados de antraciclina
ES528654A0 (es) Procedimiento para la obtencion de derivados de tetrahidrocarbazol
ES543985A0 (es) Procedimiento para preparar derivados de butiramida
ES551481A0 (es) Procedimiento de preparar derivados iminotiazolidinicos
ES545599A0 (es) Procedimiento para la obtencion de derivados de ciclohexeno-na
ES530626A0 (es) Procedimiento para preparar derivados de ciano-2-imidazopiridina
ES549076A0 (es) Procedimiento para preparar derivados de fenilpiperazina
ES547090A0 (es) Procedimiento para preparar derivados de benzazol
ES557171A0 (es) Procedimiento para preparar derivados de isoquinolinona